SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following a strong quarterly earnings report that significantly beat top and bottom-line estimates, driven by surging AI compute demand and improved foundry execution. Despite the initial jump, the stock faced volatile trading as market participants debated the long-term impact of the company's increased capital expenditure plans and broader market sentiment regarding semiconductor valuations.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the community closely monitors potential European regulatory approval for Miplyffa and reacts to a major patent extension milestone. While investors express excitement over bullish analyst upgrades and institutional buying, active community discussion remains focused on navigating the binary uncertainty of the upcoming EMA decision.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh recent regulatory successes, including label expansions for cancer treatments like Padcev, against concerns over the company's long-term growth and high dividend payout ratio. Community discussion is heavily divided between those viewing the stock as a discounted value opportunity with a sustainable yield and those frustrated by stagnant share performance and management's strategic direction.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently at the center of investor focus as the market anticipates crucial 26-week durability data from its COMP006 trial, a key milestone that could significantly accelerate the path to FDA approval for its lead depression therapy. The community is actively discussing the stock's potential as a first-mover in the psychedelic space, with many investors debating the implications of potential sector-wide acquisition interest and the clinical validation of the drug's effectiveness compared to existing treatments.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor scrutiny due to high capital expenditure, debt concerns, and a recent credit downgrade, despite receiving a multi-billion dollar Pentagon contract. While some retail investors view the current price as a buying opportunity, community sentiment remains highly polarized between those anticipating a major turnaround based on cloud demand and those fearing continued downside.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to an FDA advisory committee recommendation that could expand legal compounding access to popular peptides, a move the community views as a potential growth catalyst. Investors are actively debating the stock's future, balancing enthusiasm for this potential market expansion against volatility from short interest and ongoing skepticism regarding long-term regulatory outcomes.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is facing a selloff as investors scrutinize surging capital expenditures and negative free cash flow, despite the company reporting an earnings beat and strong cloud revenue growth. The community remains divided between those viewing the massive AI infrastructure investment as a necessary foundation for long-term dominance and those concerned about the impact of high spending on near-term profitability.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending due to massive, unusual trading volume and significant institutional accumulation, fueling community speculation about a potential short squeeze given the stock's high short interest. While bulls are focused on the company's pivot to agentic AI orchestration and its GAAP profitability, bears remain skeptical about competitive pressures and the stock's ability to maintain upward momentum.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors weigh strong earnings and surging AI-driven contract value against broader market concerns regarding enterprise software competition and geopolitical risk. While the community remains deeply divided between those viewing the stock as a fundamental 'buy-the-dip' opportunity and those concerned about margin pressure and potential AI-driven disruption, sentiment is fueled by active debates over whether software giants or chip manufacturers represent the better long-term AI play.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA approval of Auvelity for the treatment of agitation associated with Alzheimers disease, a major milestone that positions the drug for significant market expansion. Investors and the community are actively discussing the implications of this 'clean' label, the company's raised peak sales guidance, and the potential for a rapid commercial ramp-up ahead of the upcoming earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Texas South is a young, growing company with a diverse range of large scope assets. It began with participation with a first class technical partner in sub-salt projects in the Gulf of Mexico and evolved to including excellent shallow supra-salt projects that became evident from the deeper work. More recently, the company acquired an interest in a number of onshore development style projects that are adding reserves and cash flow while maintaining the scope and scale of the company’s plans.

Texas South Energy Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

TXSOTexas South Energy Inc

Fundamentals

Latest TXSO News